BioCentury
ARTICLE | Company News

Alamo Pharmaceuticals, Cima sales and marketing update

July 26, 2004 7:00 AM UTC

Alamo launched its Fazaclo orally disintegrating formulation of clozapine to treat severe schizophrenia in patients who fail to respond to standard drug treatment. The drug incorporates CIMA's OraSol...